
About Forus

Leadership

Values
Latest News
FORUS Therapeutics Inc and the Pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for XPOVIO® (selinexor)
(OAKVILLE, Ontario) May 24, 2023 – FORUS Therapeutics Inc ("FORUS") and the pan-Canadian Pharmaceutical Alliance ("pCPA") have completed negotiations with a Letter of Intent (LOI) for XPOVIO®(selinexor) in combination with bortezomib and dexamethasone for the...
FORUS Therapeutics presented at the 2023 Bloom Burton & Co. Healthcare Investor Conference
(TORONTO, Ontario) April 25-26, 2023 – It was an honour to share the FORUS Therapeutics corporate update on April 25 at the 2023 Bloom Burton & Co. Healthcare Investor Conference in Toronto. We are very proud of the important commercialization milestones our team...
WELCOME, Vania Brennan
FORUS Therapeutics is delighted to welcome Vania Brennan as Therapeutic Area Manager, Hematology/Oncology, BC/AB. Vania is well recognized as a therapeutic expert in the field of hematology and oncology with over 20 years experience in this space, in commercial and...
Contact Us
Mailing Address:
FORUS Therapeutics Inc.
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1
Phone: 1-877-359-9595
Fax: 1-877-359-9590
Patient Support:
Phone: 1-833-4YOUPSP (1-833-496-8777)
Fax: 1-833-4YOUFAX (1-833-496-8329)
Product Support:
Phone: 1-866-542-7500
Fax: 1-866-542-1100
Do not use this form to report adverse events. Adverse events can be reported at 1-866-542-7500.